HSBC Holdings’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
27,526
-40,729
-60% -$464K ﹤0.01% 2436
2026
Q1
$773K Buy
68,255
+5,888
+9% +$63.8K ﹤0.01% 1997
2025
Q4
$801K Buy
62,367
+35,062
+128% +$433K ﹤0.01% 2058
2025
Q3
$299K Buy
27,305
+10,556
+63% +$102K ﹤0.01% 2334
2025
Q2
$165K Buy
+16,749
New +$164K ﹤0.01% 2738
2025
Q1
– Sell
-44,804
Closed -$409K – 3030
2024
Q4
$409K Sell
44,804
-20,272
-31% -$149K ﹤0.01% 2296
2024
Q3
$498K Buy
65,076
+1,653
+3% +$11.9K ﹤0.01% 2009
2024
Q2
$385K Sell
63,423
-526
-0.8% -$3.25K ﹤0.01% 2131
2024
Q1
$375K Sell
63,949
-6,561
-9% -$39K ﹤0.01% 2272
2023
Q4
$554K Buy
70,510
+31,140
+79% +$216K ﹤0.01% 2012
2023
Q3
$287K Buy
39,370
+14,946
+61% +$124K ﹤0.01% 2242
2023
Q2
$259K Buy
24,424
+3,430
+16% +$33K ﹤0.01% 2216
2023
Q1
$225K Buy
20,994
+10,035
+92% +$128K ﹤0.01% 2343
2022
Q4
$151K Buy
+10,959
New +$152K ﹤0.01% 2838
2022
Q3
– Sell
-10,255
Closed -$197K – 2915
2022
Q2
$197K Sell
10,255
-1,031
-9% -$21.1K ﹤0.01% 2893
2022
Q1
$247K Buy
+11,286
New +$256K ﹤0.01% 2880
2021
Q1
– Sell
-10,947
Closed -$167K – 2713
2020
Q4
$167K Sell
10,947
-8,938
-45% -$113K ﹤0.01% 2858
2020
Q3
$238K Sell
19,885
-157
-0.8% -$1.49K ﹤0.01% 2375
2020
Q2
$204K Sell
20,042
-123
-0.6% -$1.27K ﹤0.01% 2356
2020
Q1
$210K Buy
+20,165
New +$253K ﹤0.01% 2265
2013
Q4
– Sell
-12,000
Closed -$158K – 1693
2013
Q3
$158K Buy
+12,000
New +$141K ﹤0.01% 1605

Other funds holding ANGO

HSBC Holdings's ANGO Position: Q2 2026 in Review

HSBC Holdings reduced its AngioDynamics (ANGO) stake by 60% in Q2 2026, selling an estimated $464K and leaving 27,526 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

HSBC Holdings first reported a position in ANGO in Q3 2013 and has held it in 21 quarters since. The position peaked at $801K in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • HSBC Holdings held 27,526 shares of AngioDynamics worth $356K as of Q2 2026.
  • HSBC Holdings sold 40,729 AngioDynamics shares in Q2 2026, an estimated $464K.
  • AngioDynamics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2436 holding.
  • HSBC Holdings first reported a position in AngioDynamics in Q3 2013 and has held it in 21 quarters since.
  • HSBC Holdings's AngioDynamics position peaked at $801K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.